{"disease":{"id":"microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-colorectal-cancer-in-adults-in-combination-with-nivolumab-and-ipilimumab-and-fluorouracil-leucovorin-irinotecan-and-oxaliplatin-mfolfox6-and-bevacizumab-and-cetuximab-and-panitumumab.md","name":"microsatellite instability high msi h or mismatch repair deficient dmmr colorectal cancer in adults in combination with nivolumab and ipilimumab and fluorouracil leucovorin irinotecan and oxaliplatin mfolfox6 and bevacizumab and cetuximab and panitumumab.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}